The high complexity and diversity of the eukaryotic transcriptome poses significant challenges for the efficient detection of specific transcripts. Conventional targeted RNA-seq methods often require ...
Moxham currently leads Transcripta Bio as founder and CEO. The AI-driven drug discovery start-up is developing small molecule therapeutics to modulate gene expression disease signatures. ...
Early-onset cancer signature (EOCS): Pan-cancer molecular alterations with prognostic significance in early-onset (EOC) and late-onset (LOC) cancer. Pan-cancer KRAS atlas of 9,056 Chinese patients: ...
Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best IPO stocks with huge upside potential. On July 1, Caris Life announced the commercial launch of Caris Detect, a multi-cancer early detection ...
Genetic variants that cause rare disorders may remain elusive even after expansive testing, such as exome sequencing. The diagnostic yield of genome sequencing, particularly after a negative ...
Low-dose radiation as a preconditioning regimen for dendritic cell vaccines. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
This eBook explores advances in RNA sequencing (RNA-seq), with key content from BioTechniques’ digital hub and Taylor & Francis journals, Biotechnology and Genetic Engineering Reviews, Immunological ...
BHUBANESWAR: The Institute of Medical Sciences (IMS) and SUM hospital has become the first healthcare facility in the state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results